Search results
Results from the WOW.Com Content Network
Dysthymia (/ d ɪ s ˈ θ aɪ m i ə / dihs-THIY-mee-uh), also known as persistent depressive disorder (PDD), [3] is a mental and behavioral disorder, [5] specifically a disorder primarily of mood, consisting of similar cognitive and physical problems as major depressive disorder, but with longer-lasting symptoms.
Pervasive developmental disorder not otherwise specified (PDD-NOS), which includes atypical autism, and is the most common (47% of autism diagnoses); [10] Typical autism, the best-known; Asperger syndrome (9% of autism diagnoses); Rett syndrome; and; Childhood disintegrative disorder (CDD).
PDD-NOS is not a current part of the Diagnostic and Statistical Manual of Mental Disorders typology (as of the DSM-5), which is the most common diagnostic typology used in the United States. In the still used (though deprecated) ICD-10, it is considered "atypical autism" and "pervasive developmental disorder, unspecified". [8]
The intravenous PDD treatment Zulresso, also made by Sage, costs $34,000 a year. At least two analysts said the wholesale acquisition price of $15,900 for the course of treatment with Zurzuvae was ...
.51 Mild.52 Moderate.53 Severe without psychotic features.54 Severe with psychotic features.50 Unspecified.40 Bipolar I disorder, most recent episode hypomanic.4x Bipolar I disorder, most recent episode manic.46 In full remission.45 In partial remission.41 Mild.42 Moderate.43 Severe without psychotic features.44 Severe with psychotic features
Treatment often involves promoting better communication and socializing, and reducing behaviors that can be disruptive. Children with pervasive developmental disorders may be placed in special education classes, receive behavior modification training, speech, physical or occupational therapy, or medication.
Parkinson's disease is a risk factor for PDD; it speeds up decline in cognition leading to PDD. [2] Up to 78% of people with PD have dementia. [2] Delusions in PDD are less common than in DLB, [2] and persons with PD are typically less caught up in their visual hallucinations than those with DLB. [7]
Modafinil is sometimes used successfully as an off-label treatment option. [ 14 ] Before the year 2000, monoamine oxidase inhibitors (MAOIs) were shown to be of superior efficacy compared to other antidepressants for the treatment of atypical depression, and were used as first-line treatment for this clinical presentation.